The rationale for the use of dimercaprol, a sulphydryl-containing compound, as a specific antidote is discussed with reference to the pharmacodynamics of paracetamol. A recommended plan of management is presented.
References
1.
BucknerC. Dean (1973): “Plasma Exchange in Patients with Fulminant Hepatic Failure”, Arch. Intern. Med., 132, 487.
2.
BurnR. (1073): “Blood Glucose in Paracetamol Poisoning”, Lancet, 1, 728.
3.
ClarkR. (1973): “Hepatic Damage and Death from Overdose of Paracetamol”, Lancet, 1, 66.
4.
DavidsonD. G. D., and EasthamW. N. (1966): “Acute Liver Necrosis Following Overdose of Paracetamol”, Brit. Med. J., 2, 497.
5.
MacleanD. (1968): “Treatment of Acute Paracetamol Poisoning”, Lancet, 2, 849.
6.
MitchellJ. R. (1973): “Paracetamol—Induced Hepatic Injury: Biochemical Rationale for Possible Therapy”, Personal communication.
7.
PrescottL. F. (1971): “Plasma Paracetamol Half-life and Hepatic Necrosis in Patients with Paracetamol Overdosage”, Lancet, 1, 519.
8.
PrescottL. F. (1974): “Successful Treatment of Severe Paracetamol Overdosage withCysteamine”, Lancet, 1, 588.
